Stock Events

Stock Events

Ceapro 

C$0.2250
15
-C$0.03-11.76% Friday 17:07

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

9NovExpected
Q2 2020
Q3 2020
Q1 2021
Q2 2021
Q3 2021
Q1 2022
Q3 2022
-0.01
-0
0
0.01
Expected EPS
N/A
Actual EPS
N/A

Financials

-Profit Margin
Unprofitable
2018
2019
2020
2021
2022
2023
0Revenue
0Net Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Basf
BASFY
Mkt Cap47.72B
BASF SE operates in the same biochemical sector, producing ingredients for personal care products, which competes directly with Ceapro's active ingredients offerings.
BNY Mellon Strategic Municipal Bond Fund
DSM
Mkt Cap288.17M
Koninklijke DSM N.V. is involved in health, nutrition, and materials, which overlaps with Ceapro's work in natural health products and functional ingredients.
DuPont de Nemours
DD
Mkt Cap18.5B
DuPont de Nemours, Inc. provides various science-based products in nutrition & biosciences, competing in the same space as Ceapro's bioactive ingredient production.
Crocs
CROX
Mkt Cap5.86B
Croda International Plc focuses on creating and selling specialty chemicals for a wide range of industries, including personal care, which competes with Ceapro's natural ingredient products.
International Flavors & Fragrances
IFF
Mkt Cap22.44B
International Flavors & Fragrances Inc. works in creating tastes and scents, which includes the development of active ingredients for personal care, competing with Ceapro.
Symrise
SYIEY
Mkt Cap14.21B
Symrise AG is a global supplier of fragrances, flavorings, cosmetic active ingredients, and raw materials, competing in the same market as Ceapro.
L`Oreal
LRLCY
Mkt Cap231.01B
L'Oréal S.A. is primarily known for its cosmetics, but its active investment in research and development of innovative skincare ingredients competes with Ceapro's innovations.

About

Ceapro Inc., a biotechnology company, engages in the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using proprietary technology, natural, and renewable resources in the United States, Germany, China, Canada, and internationally. The company is involved in the development of proprietary extraction technologies and the application of the technologies to the production, development, and commercialization of active ingredients, such as oat beta glucan and avenanthramides, which are derived from oats and other renewable plant resources for healthcare and cosmetic industries. It also develops and commercializes active ingredients derived from oats and other renewable plant resources for healthcare and cosmetic industries. The company was incorporated in 1997 and is headquartered in Edmonton, Canada. As of June 3, 2024, Ceapro Inc. operates as a subsidiary of Aeterna Zentaris Inc.
Show more...
CEO
Mr. Gilles R. Gagnon ICD.D, M.B.A., M.Sc.
Country
Canada
ISIN
CA1499071076

Listings

0 Comments

Share your thoughts

FAQ

What is Ceapro stock price today?▼
The current price of CZO.V is C$0.23 CAD — it has decreased by -11.76% in the past 24 hours. Watch Ceapro stock price performance more closely on the chart.
What is Ceapro stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on TSX Venture Exchange exchange Ceapro stocks are traded under the ticker CZO.V.
What is Ceapro revenue for the last year?▼
Ceapro revenue for the last year amounts to 0 CAD.
What is Ceapro net income for the last year?▼
CZO.V net income for the last year is 0 CAD.
In which sector is Ceapro located?▼
Ceapro operates in the Health & Wellness sector.
When did Ceapro complete a stock split?▼
Ceapro has not had any recent stock splits.
Where is Ceapro headquartered?▼
Ceapro is headquartered in Edmonton, Canada.